Filtered By:
Cancer: Colorectal Cancer

This page shows you your search results in order of relevance. This is page number 20.

Order by Relevance | Date

Total 51727 results found since Jan 2013.

A study on the effect of nutrition education based on the goal attainment theory on oral nutritional supplementation after colorectal cancer surgery
CONCLUSION: Nutritional education based on the Goal Attainment Theory can effectively improve the adherence to oral nutritional supplementation therapy and protein intake attainment rate of colorectal cancer patients after surgery and effectively improve the nutritional status of patients.PMID:37410217 | DOI:10.1007/s00520-023-07905-1
Source: Cancer Control - July 6, 2023 Category: Cancer & Oncology Authors: Jun-Fang Pi Jing Zhou Ling-Ling Lu Lan Li Chen-Rong Mao Ling Jiang Source Type: research

Systematic Search for Present and Potential Portals of Entry for Infective Endocarditis
ConclusionsOur search for the POEs of present IEs was often successful, as was searching for an oral or dental or a gastrointestinal POE of a new IE episode. We advise the systematic performance of stomatologic examinations in patients with IE and performance of colonoscopy in patients ≥50 years of age or at high risk for colorectal cancer.
Source: Journal of the American College of Cardiology - January 12, 2016 Category: Cardiology Source Type: research

A Culturally Adapted Colorectal Cancer Education Video for the Somali Community in Minnesota: A Pilot Investigation
CONCLUSION: These results provide evidence of usefulness of culturally tailored videos to facilitate CRC screening in the Somali community. Results of this study were limited by a small sample size and lack of a control group.PMID:34889127 | DOI:10.1177/08901171211057690
Source: Cancer Control - December 10, 2021 Category: Cancer & Oncology Authors: Motohiro Nakajima Abdifatah Haji Sakhaudiin Mohamud Osmon Ahmed James S Hodges Rebekah Pratt Source Type: research

"Don't Know" Responses to Risk Perception Measures: Implications for Underserved Populations
Conclusions: "Don’t know" responding is more prevalent in populations affected by health disparities. Either not assessing or not analyzing DK responses could further disenfranchise these populations and negatively affect the validity of research and the efficacy of interventions seeking to eliminate health disparities.
Source: Medical Decision Making - February 27, 2013 Category: Health Management Authors: Waters, E. A., Hay, J. L., Orom, H., Kiviniemi, M. T., Drake, B. F. Tags: Original Articles Source Type: research

Eosinophilic small bowel enteritis in response to folinic acid, fluorouracil, and oxaliplatin chemotherapy.
Abstract A 70-year-old woman being treated with folinic acid, fluorouracil, and oxaliplatin (FOLFOX) therapy for relapsed colon cancer metastatic to the lung presented to the hospital with a 1-week history of abdominal pain, anorexia, a 1-day history of diarrhea, and a fever of 101°F. Neutropenia and a peripheral eosinophilia were present, and computed tomogram of the abdomen showed thickening of the wall of a segment of small bowel with luminal stenosis. Colonoscopy and double-balloon small bowel enteroscopy found a stenosis in the ileum that upon biopsy revealed small bowel eosinophilic enteritis. She improved ...
Source: Baylor University Medical Center Proceedings - July 1, 2013 Category: Universities & Medical Training Authors: Pearson EJ, Mennel R Tags: Proc (Bayl Univ Med Cent) Source Type: research

Implementing family health history risk stratification in primary care: Impact of guideline criteria on populations and resource demand
The Genomic Medicine Model aims to facilitate patient engagement, patient/provider education of genomics/personalized medicine, and uptake of risk‐stratified evidence‐based prevention guidelines using MeTree, a patient‐facing family health history (FHH) collection and clinical decision support (CDS) program. Here we report the number of increased risk (above population‐level risk) patients identified for breast/ovarian cancer, colon cancer, hereditary syndrome risk, and thrombosis; the prevalence of FHH elements triggering increased‐risk status; and the resources needed to manage their risk. Study design: hybrid ...
Source: American Journal of Medical Genetics Part C: Seminars in Medical Genetics - March 10, 2014 Category: Genetics & Stem Cells Authors: Lori A. Orlando, R. Ryanne Wu, Chris Beadles, Tiffany Himmel, Adam H. Buchanan, Karen P. Powell, Elizabeth R. Hauser, Vincent C. Henrich, Geoffrey S. Ginsburg Tags: Research Article Source Type: research

Communicating bodily changes: Physicians' ways of enabling patient understanding in gastrointestinal cancer consultations.
Abstract Objective: To explore how physicians communicatively enable patients' understanding of bodily changes in gastrointestinal cancer care consultations. Method: Two datasets were used. The first consisted of transcribed video-recorded palliative care consultations with three oncologists and six patients diagnosed with advanced gastrointestinal cancer, in the context of outpatient palliative care. The second dataset was audio-recorded transcriptions from diagnostic consultations with six surgeons and seven patients diagnosed with colorectal cancer, in the context of cancer surgery. An inductively driven and it...
Source: Palliative and Supportive Care - May 2, 2014 Category: Palliative Care Authors: Friberg F, Lidén E, Håkanson C, Ohlén J Tags: Palliat Support Care Source Type: research

Do Cancer Patients Tweet? Examining the Twitter Use of Cancer Patients in Japan
Conclusions: This study demonstrates that cancer patients share information about their underlying disease, including diagnosis, symptoms, and treatments, via Twitter. This information could prove useful to health care providers.
Source: Journal of Medical Internet Research - May 27, 2014 Category: Journals (General) Authors: Atsushi TsuyaYuya SugawaraAtsushi TanakaHiroto Narimatsu Source Type: research

Abstract 5555: Pharmacogenetics-pharmacokinetics study of bevacizumab in mCRC patients treated with Avastin-Folfiri regimen: Search for predictive markers of response and study of the pharmacokinetics variability
Identifying biomarkers predictive of response is a rising trend in clinical oncology, especially when administrating costly targeted therapies and biologics. Unlike other monoclonal antibodies such as cetuximab, panitumumab, trastuzumab or ipilimumab, search for genetic or molecular makers predictive for clinical outcome with widely prescribed bevacizumab has failed to generate consensual results over the last decade. We have performed a pilot study in 70 patients with metastatic colorectal cancer receiving the standard bevacizumab-Folfiri protocol. More specifically, our study focused on the retrospective screening of the...
Source: Cancer Research - September 30, 2014 Category: Cancer & Oncology Authors: Chantry, A.-S., Ciccolini, J., Sibertin-Blanc, C., Dahan, L., Olschwang, S., Seitz, J., Lacarelle, B. Tags: Experimental and Molecular Therapeutics Source Type: research

Prodigiosin isolated from cell wall of Serratia marcescens alters expression of apoptosis-related genes and increases apoptosis in colorectal cancer cells
Abstract Colorectal cancer remains often refractory to classic therapies. In consequence, the search for new anti-tumor agents with minimal toxicity is of particular interest in colon cancer treatment. Prodigiosin as a secondary metabolite of Serratia marcescens induces apoptosis in various kinds of cancer cells with low toxicity on normal cells. In the present study, we evaluated the effect of prodigiosin on proliferation and expression of apoptotic-related genes in HT-29 cells. Malignant cells were treated to various concentrations of prodigiosin and proliferation rate, survivin, Bcl-2, Bax and Bad mRNA levels,...
Source: Medical Oncology - November 28, 2014 Category: Cancer & Oncology Source Type: research

Stool DNA Test for Colorectal Cancer Screening
The FDA has approved a stool DNA test to screen average-risk adults aged 50 years or older for colorectal cancer.
Source: JAMA Oncology - December 18, 2014 Category: Cancer & Oncology Authors: From The Medical Letter on Drugs and Therapeutics Tags: Clinical Review & Education From The Medical Letter on Drugs and Therapeutics JAMA Source Type: research

Effect of Proliferator-Activated Receptor-γ Pro12Ala Polymorphism on Colorectal Cancer Risk: A Meta-Analysis.
CONCLUSIONS In summary, this study suggests that PPARγ Pro12Ala polymorphism was a protective factor of CRC. PMID: 26049557 [PubMed - in process]
Source: Medical Science Monitor - June 10, 2015 Category: Research Tags: Med Sci Monit Source Type: research